IA
INDV icon

IFP Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

IFP Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.47K Sell
109
-382
-78% -$13.9K ﹤0.01% 3860
2026
Q1 		$16K Buy
491
+203
+70% +$6.7K ﹤0.01% 2899
2025
Q4 		$10.3K Buy
288
+287
+28,700% +$8.76K ﹤0.01% 3051
2025
Q3 		$24 Hold
1
– – ﹤0.01% 4738
2025
Q2 		$15 Hold
1
– – ﹤0.01% 4862
2025
Q1 		$10 Hold
1
– – ﹤0.01% 4231
2024
Q4 		$12 Hold
1
– – ﹤0.01% 4516
2024
Q3 		$10 Hold
1
– – ﹤0.01% 3286
2024
Q2 		$16 Hold
1
– – ﹤0.01% 3208
2024
Q1 		$21 Hold
1
– – ﹤0.01% 3092
2023
Q4 		$15 Hold
1
– – ﹤0.01% 3015
2023
Q3 		$23 Hold
1
– – ﹤0.01% 3255
2023
Q2 		$24 Buy
+1
New +$23 ﹤0.01% 3415

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IFP Advisors's INDV Position: Q2 2026 in Review

IFP Advisors reduced its Indivior Pharmaceuticals (INDV) stake by 78% in Q2 2026, selling an estimated $13.9K and leaving 109 shares worth $4.47K. The position accounts for ﹤0.01% of the portfolio, ranked #3860.

IFP Advisors first reported a position in INDV in Q2 2023 and has held it in 13 quarters since. The position peaked at $16K in Q1 2026. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • IFP Advisors held 109 shares of Indivior Pharmaceuticals worth $4.47K as of Q2 2026.
  • IFP Advisors sold 382 Indivior Pharmaceuticals shares in Q2 2026, an estimated $13.9K.
  • Indivior Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3860 holding.
  • IFP Advisors first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • IFP Advisors's Indivior Pharmaceuticals position peaked at $16K in Q1 2026.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.